Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Carcinoma

Explore clinical trials studying Neuroendocrine Carcinoma. Study availability and eligibility vary by location and protocol.

52 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Carcinoma trial results

Completed

PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers

NCT02936323

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations
  • Florida Cancer Specialists South Fort Myers, Florida, United States
  • Florida Cancer Specialists North St. Petersburg, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

Avelumab in G3 NEC

NCT03278405

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations
  • Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
View Trial Details
Completed

Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers

NCT01121939

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
  • Medical Oncology Associates of Augusta Augusta, Georgia, United States
  • Baptist Medical Center East Louisville, Kentucky, United States
View Trial Details
Completed

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

NCT00363051

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +18 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • USC Medical Center Los Angeles, California, United States
  • Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 54 locations
View Trial Details

Related conditions